iGEM 2019 — Team Rotterdam_HR

[![](https://2019.igem.org/wiki/images/8/8b/HQ_page_logo.jpg)](https://2019.igem.org)

# Team:Rotterdam HR/Notebook

# Notebook

Document the dates you worked on your project. This should be a detailed account of the work done each day for your project.

### What should this page have?

* Chronological notes of what your team is doing.
* Brief descriptions of daily important events.
* Pictures of your progress.
* Mention who participated in what task.

### Inspiration

You can see what others teams have done to organize their notes:

* [2018 Munich](https://2018.igem.org/Team%3AMunich/Notebook)
* [2014 ATOMS-Turkiye](https://2014.igem.org/Team%3AATOMS-Turkiye/Notebook)
* [2014 Tec Monterrey](https://2014.igem.org/Team%3ATec-Monterrey/ITESM14_project.html#tab_notebook)
* [2014 Kyoto](https://2014.igem.org/Team%3AKyoto/Notebook/Magnetosome_Formation#title)
* [2014 Cornell](https://2014.igem.org/Team%3ACornell/notebook)


[![](https://2019.igem.org/wiki/images/8/8b/HQ_page_logo.jpg)](https://2019.igem.org)

# Team:Rotterdam HR/Experiments

![](https://static.igem.org/mediawiki/2019/e/e9/T--Rotterdam_HR--logo.png)

# iGEM Rotterdam HR 2019

* [Home](https://2019.igem.org/Team%3ARotterdam_HR)

Team

[Members](https://2019.igem.org/Team%3ARotterdam_HR/Members)
 [Collaborations](https://2019.igem.org/Team%3ARotterdam_HR/Collaborations)

Project

[Description](https://2019.igem.org/Team%3ARotterdam_HR/Description)
 [Safety](https://2019.igem.org/Team%3ARotterdam_HR/Safety)

Human Practices

[iGEM Squeeze](https://2019.igem.org/Team%3ARotterdam_HR/iGEMSqueeze)
 [Human Practices](https://2019.igem.org/Team%3ARotterdam_HR/Human_Practices)
 [Public Engagement](https://2019.igem.org/Team%3ARotterdam_HR/PublicEngagement)
 [Outreach](https://2019.igem.org/Team%3ARotterdam_HR/Outreach)

Acknowledgements

[Attributions](https://2019.igem.org/Team%3ARotterdam_HR/Attributions)
 [Sponsors](https://2019.igem.org/Team%3ARotterdam_HR/Sponsors)

Design

[Design](https://2019.igem.org/Team%3ARotterdam_HR/Design)

Lab

[Biobrick Parts](https://2019.igem.org/Team%3ARotterdam_HR/BioBricks)
 [DryLab](https://2019.igem.org/Team%3ARotterdam_HR/Drylab)
 [Notebook](https://2019.igem.org/Team%3ARotterdam_HR/NoteBook)
 [Results](https://2019.igem.org/Team%3ARotterdam_HR/Results)
 [Protocols](https://2019.igem.org/Team%3ARotterdam_HR/Experiments)

Future

[Future plans for our HRDK](https://2019.igem.org/Team%3ARotterdam_HR/Future)

# Protocols

[Here you can find the protocols we used for our experiments.](https://static.igem.org/mediawiki/2019/9/95/T--Rotterdam_HR--experimentsHR2019.pdf)

# Digestion

x µL DNA

2 µL 10x restriction buffer y µL Milli-Q water

Mix well and finally add: 1 µL restriction enzyme (1 U/µL)

Total volume: 20 µl

At https://www.neb.com/tools-and-resources/usage-guidelines/nebuffer-performance-chart-with-restrictionenzymes you can see which buffer you need as well as the incubation and heat inactivation temperatures.

# Dephosphorylation and Ligation

Dephosphorylation

 If necessary, dephosphorylate 1 of the 2 DNA fragments that need to be ligated, for example only the vector
DNA according to the following scheme:

x µl (1 µg) DNA

2.5 µl Phosphatase buffer (10x)

 y µl Milli-Q

 Mix well and finally add: 1 µl Phosphatase (1 U / µl)

Total volume: 25 µl

Mix well and centrifuge briefly. Incubate for 10 minutes at 37 C. Then inactivate the enzyme by placing the mixture at 75 C for 2 minutes.

Ligation

x µl (100 ng) (dephosphorylated) vector DNA (pSB1C3 for example)(… ng/µl)

y µl ( .. ng) fragment DNA (… ng/µl)

4 µl 5x T4 ligation buffer

 z µl Milli-Q

 Mix well and finally add: 1 µl T4 DNA ligase (1 U/ µl)

Total volume: 20 µl

For the dephosphorylation control, you will leave out the fragmented DNA and use more Milli-Q.

Mix well and centrifuge briefly. Incubate for 20 minutes at room temperature.

# TEV Cleaving assay

The following protocol has been set-up after talking to Eddy van der Linden (Biochemist Lecturer University of Rotterdam) and Sari van Rossum(analyst at Erasmus University).

From 100 mM stock DTT, the final concentration must be 1 mM DTT.

1 M Tris-HCl buffer with 10 mM DTT, pH 8.0 (20x buffer)

 Make 100 ml of 20x concentrated buffer. Do this as follow:

10 mM DTT = 0.1542 grams.

Tris: 121.14 g/L, so for 100 mL you take 12.114 g. Dissolve this in 80 ml of dH2O.

 Add the 0.1542 g DTT.

Measure the pH and adjust it to 8.0 with 1 M HCl.

Add dH2O till 100 mL.

50 µl TEV protease is contained in a tube, donated by the Erasmus Medical Center (EMC) in Rotterdam.

 The number of units per mg = 3000 U.

We want a final concentration of 10U in 150µl.

The concentration is 0.8 µg/µl = 3000/1000 \* 0.8 = 2.4U/µl.

So 10U / 2.4 U/µl = 4.2µl TEV is added to the tubes.

Fusion protein (GST-TEVcleavingsite-BRCA2) is 20 µg (also donated by EMC), or 10 µl (if the concentration is not known) -> with known concentration this is also 10 µl.

Tube 1:

 - 4.2 µl TEV

 - 7.5 µl 20x Buffer

 - 1.5 µl 100 mM DTT

 - 136.8 µl dH2O

Tube 2:

 - 7.5 µl 20x Buffer

 - 1.5 µl 100 mM DTT

 - 10 µl BRCA2

- 131 µl dH2O

Tube 3:

- 4.2 µl TEV

 - 7.5 µl 20x Buffer

 - 1.5 µl 100 mM DTT

 - 10 µl BRCA2

 - 126.8 µl dH2O

- Incubate the mixture at 30 °C.

- Take 3 times a 50 µl sample after 1, 2 and 4 hours respectively.

- Load all this on an SDS-PAGE gel.

# SDS-PAGE Electrophoresis

Wash the glass plates with a sponge and soap, then rinse it with a spray bottle with ethanol and dry the plates well.

Place the glass plates in the gel holder.

 Place the comb between the glass plates and mark up to ± 1.5 cm below the bottom of the comb.

 Make the running gel (12% acrylamide/bisacrylamide gel) as follow:

![](https://static.igem.org/mediawiki/2019/4/4f/T--Rotterdam_HR--exp6.png)

Mix well and pipette this solution until the mark is reached.
Carefully pipette 0.5 mL of butanol on top of the running gel solution. Ensure that no mixing occurs. This covering is necessary to obtain a nice straight surface of the gel and to seal off the gel for oxygen from the air.

Allow the gel to polymerize for approx. 15 minutes.
Remove the butanol from the polymerized running gel with a folded tissue and discard it in the acrylamide waste container.

Make the solution for the stacking gel:

![](https://static.igem.org/mediawiki/2019/9/9f/T--Rotterdam_HR--exp5.png)

Pipette on the polymerized running gel so much stacking gel solution until the top of the glass plates is reached. Immediately insert the 10 slots comb carefully into the stacking gel and allow it to polymerize for approx. 20 minutes.

Grab the tubes with the fractions that you are going to put on gel.

Pipette 36 μL each time in a new tube.

Add 12 μL 4x sample buffer to these tubes.

Heat these samples (not the Blue protein standard) in a heat block for 5 minutes at 95 °C.

Then centrifuge the tubes shortly.

Connect the electrophoresis device to a voltage source. Use a voltage of 60 V until the samples have passed through the stacking gel. After this, use a voltage of 120 V until the blue band has almost reached the bottom of the gel.

Remove the gel from the glass plates. Coloring is done in a large Petri dish with Instant Blue. If the color is optimal, the gel can be analyzed by using the Gel Doc EZ imaging system.

# DNA Electrophoresis

- Prepare 800 mL of 1 x TAE buffer.

- Prepare 100 ml of 0.8% agarose solution in the 1 x TAE buffer in a 250 ml Erlenmeyer flask.

- Bring the suspension (in the microwave) to let it boil until all agarose particles have dissolved. Make sure that it is hand warm.

- In the meantime, take all the parts that you need for electrophoresis.

- Tape the gel holder wall with masking tape.

- Place the comb in the gel holder in the recesses made for this.

- Add 100 µL Gelred solution to the hand warm agarose solution and mix well, remove any air bubbles (with a pasteurized pipette or pipette tip) and allow the gel to solidify. Do not move it during the solidification process. Immediately rinse the Erlenmeyer flask with plenty of warm water.

- If the gel has solidified (10 - 15 minutes), you can remove the tape and put the gel holder in the electrophoresis device.

- Pour so much 1 x TAE buffer into the electrophoresis tray that the buffer just flows over the gel. Then carefully remove the comb from the gel. Check whether the locks are filled with buffer. Test if a current is going to run and check the electrophoresis direction.

# Competent cells

1) Remove a single colony from an LB plate and inoculate it in a tube with 5 ml of LB medium. Incubate overnight at 37 C in the shaker (200 rpm). This must be done the day before the experiment!

2) On the day of the experiment: Dilute the overnight (O/N) culture 1: 100 in LB in 20 ml LB with 20 mM MgSO4 in 100 ml flask. Incubate at 37 °C in a shaker. (200 rpm) until the culture has an A600 of approximately 0.5 (between 0.4 and 0.6) relative to the blank (LB medium with 20 mM MgSO4). To measure absorbance in between, preferably use a plastic cuvette that is rinsed with alcohol after each measurement.

3) Centrifuge 10 ml of the culture for 5 minutes at 2500 rpm and 4 °C in a sterile Greiner tube. Estimate the volume here. (= initial volume).

4) Absorb the cells gently at 0.4 times the initial volume in ice-cold Tfb1. For 10 ml this is therefore 4 ml. Resuspend the cells by tapping by hand or sucking up with a Pasteur pipette and pipetting again. The cells must remain cold!

5) Incubate the cells on ice for 15 minutes.

6) Pellet the cells by spinning for 5 minutes at 2500 rpm and 4 °C.

7) Gently absorb the cells in 1/25 of the initial volume in ice-cold Tfb2. 400 µl for a 10 ml culture. You then have enough for 8 transformations.

If the cells are stored: 15-60 minutes on ice, then freeze quickly (“snap freeze” in liquid nitrogen or a mixture of dry ice and isopropanol).

# Transformation

Protocol: Single Tube Transformation Protocol, iGEM

1. Resuspend DNA in selected wells in the Distribution Kit with 10µl dH20. Pipet up and down several times, let sit for a few minutes. Resuspension will be red from the cresol red dye.

2. Label 1.5ml tubes with the part name or well location. Fill lab ice bucket with ice, and pre-chill 1.5ml tubes (one tube for each transformation, including your control) in a floating foam tube rack.

3. Thaw competent cells on ice: This may take 10-15min for a 260µl stock. Dispose of unused competent cells. Do not refreeze unused thawed cells, as it will drastically reduce transformation efficiency.

4. Pipette 50µl of competent cells into 1.5ml tube: 50µl in a 1.5ml tube per transformation. Tubes should be labeled, pre-chilled, and in a floating tube rack for support. Keep all tubes on ice. Don’t forget a 1.5ml tube for your control.

5. Pipette 1µl of resuspended DNA into 1.5ml tube: Pipette from well into an appropriately labeled tube. Gently pipette up and down a few times. Keep all tubes on ice. Pipette 1µl of control DNA into 2ml tube: Pipette 1µl of 10pg/µl control into your control transformation. Gently pipette up and down a few times. Keep all tubes on ice.

6. Close 1.5ml tubes, incubate on ice for 30min: Tubes may be gently agitated/flicked to mix the solution, but return to ice immediately.

7. Heat shock tubes at 42°C for 45 sec: 1.5ml tubes should be in a floating foam tube rack. Place in a water bath to ensure the bottoms of the tubes are submerged. Timing is critical.

8. Incubate on ice for 5min: Return transformation tubes to an ice bucket.

9. Pipette 950µl SOC media to each transformation: SOC should be stored at 4°C, but can be warmed to room temperature before use. Check for contamination.

10. Incubate at 37°C for 1 hour, shaking at 100rpm.

11. Pipette 100µL of each transformation onto Petri plates. Spread with a sterilized spreader or glass beads immediately. This helps ensure that you will be able to pick out a single colony.

12. Spin down cells at 6800g for 3mins and discard 800µL of the supernatant. Resuspend the cells in the remaining 100µL, and pipette each transformation onto Petri plates with an antibiotic, Spread with a sterilized spreader or glass beads immediately. This increases the chance of getting colonies from lower concentration DNA samples.

13. Incubate transformations overnight (24 hr) at 37°C: Incubate the plates upside down (agar side up). If incubated for too long, colonies may overgrow and the antibiotics may start to break down; un-transformed cells will begin to grow.

# DNA isolation

Protocol: Miniprep Zymo Research

1. Centrifuge 3 ml of bacterial culture in a clear 1.5 ml tube at full speed for 20 seconds in a microcentrifuge. Discard supernatant.

2. Add 250 µl of P1 Buffer (Red) to the tube and resuspend pellet completely (i.e., by vortexing or pipetting).

3. Add 250 µl of P2 Buffer (Green) and mix by inverting the tube 6 - 8 times. Do not vortex! Let sit at room temperature for 3 minutes. Cells are completely lysed when the solution appears clear, purple, and viscous.

4. Add 250 µl of ice-cold P3 Buffer (Yellow) and mix gently but thoroughly. Do not vortex. Invert the tube an additional 3-4 times after the sample turns completely yellow. The sample will turn yellow when the neutralization is complete.

5. Incubate the neutralized lysate on ice for 5 minutes.

6. Centrifuge the neutralized lysate for 5 minutes at 16,000 x g.

7. Transfer 600 µl of the supernatant from step 6 into a clean 1.5 mL microcentrifuge tube. Be careful not to disturb the yellow pellet and avoid transferring any cellular debris to the new tube.

8. Add 275 µl of ZymoPURE binding buffer to the cleared lysate from step 7 and mix thoroughly by inverting the capped tube 8 times.

9. Place a Zymo-Spin II-P column in a Collection Tube and transfer the entire mixture from step 8 into the Zymo-Spin II-P Column.

10. Incubate the Zymo-SPin II-P/Collection Tube assembly at room temperature for 2 minutes and then centrifuge at 5000 x g for 1 minute. Discard the flow-through.

11. Add 800 µl of ZymoPURE Wash 1 to the Zymo-Spin II-P Column and centrifuge at 5000 x g for 1 min. Discard the flow-through.

12. Add 800 µl of ZymoPURE Wash 2 to the Zymo-spin II-P Column and centrifuge at 5,000 x g for 1 min. Discard the flow-through. Repeat this wash step with 200 µl of ZymoPURE Wash 2.

13. Place the Zymo-Spin II-P Column in a Collection Tube and transfer it to a microcentrifuge. Centrifuge at > 10,000 x g for 1 minute in order to remove any residual wash buffer.

14. Transfer the Zymo-Spin II-P Column into a clean 1.5 mL tube and add 25 µl of ZymoPURE Elution Buffer directly to the column matrix. Incubate at room temperature for 2 minutes, and then centrifuge at > 10,000 x g for 1 minute in a microcentrifuge.

# Nitrocefin

Protocol from: https://microbeonline.com/nitrocefin-test-principle-procedure-uses-limitations/

Prepare a 0.5 mM Nitrocefin solution. Do this by weighing 2.58 mg on an analytical balance and dissolving this in 500 µl DMSO (Do this is in a fume hood!). Then complete this with 9.5 ml of 0.1 M phosphate buffer (pH 7.0).

Take a clean object glass and pipette 20 µl of 0.1 M phosphate buffer (pH 7.0).

Scrape a colony off the plate with an öse or sterile Pasteur pipette and suspend it in the 20 µl on the object-glass.

Now add 20 µl of the Nitrocefin solution. The color should change to red within 1-2 minutes (maximum 10).

Remarks:

- The solution is stable for 10 days at 4 ° C, wrapped in aluminum foil.

- Glass must be used because DMSO breaks down plastic.

- A weak activity of β-lactamase can prolong the reaction time, anything that lasts longer than 10 minutes must be critically examined.

# Annealing

Resuspend the gBLOCK DNA (3000 ng) with 30µl dH20 to get an end concentration of 100 ng/µL.

Protocol from: https://www.sigmaaldrich.com/technical-documents/protocols/biology/annealing-oligos.html

Annealing buffer 10x:

- 1 mL 1M Tris pH 8.0

- 5 mL of 1 M NaCl

- 0.2 mL of 0.5 M EDTA

- 3.8 mL of demi water

Sterilize Annealing buffer with a 0,22 µm filter.
![](https://static.igem.org/mediawiki/2019/8/80/T--Rotterdam_HR--exp4.png)

Thermocycler settings:

1. Mix equal volumes of the oligonucleotides in a PCR tube.

 2. Use the following thermal profile:

a. Heat\* to 95 °C and maintain the temperature for 2 min.

b. Cool to 25 °C for over 45 min.

 c. Cool to 4 °C for temporary storage.

3. Centrifuge the PCR tube briefly to draw all moisture away from the lid.

\* The lid will be set on 100 °C

# TEV-cleaving site – β-Lactamase

![](https://static.igem.org/mediawiki/2019/6/6c/T--Rotterdam_HR--exp2.png)

 C-terminal: Use XbaBlaPF primer in combination with SpeBlaTEVR with pUC18 as a template (see table 1). Digest the PCR product with XbaI and SpeI and clone in pSB1C3 between the XbaI and SpeI sites.

N-terminal: We need two fragments for this. Use the primers XbaBlaPF and BlaPSSTEVR for fragment 1 and TEVBlaF and BlaSpeR for fragment 2 and pUC18 as a template (see table 1). Purify both fragments and merge them in a "fusion PCR" where you now only use the outer primers, XbaBlaPF and BlaSpeR (see table 2). The outer primers contain the RFC10 prefix or suffix site. The long product thus obtained is purified and digested again with XbaI and SpeI and cloned in pSB1C3.

![](https://static.igem.org/mediawiki/2019/7/72/T--Rotterdam_HR--exp3.png)

PCR clean-up protocol from Macherey-Nagel: https://www.mn- net.com/Portals/8/attachments/Redakteure\_Bio/Protoc ols/DNA%20clean- up/UM\_PCRcleanup\_Gelex\_NSGelPCR.pdf

![](https://static.igem.org/mediawiki/2019/8/85/T--Rotterdam_HR--exp1.png)

# Chromoprotein characterization

• Transform the BioBricks into DH5α-cells.

 • The next day an O/N culture (300 mL LB medium with chloramphenicol) will be prepared, incubate this at 37 C in a shaker (200 rpm) for 24 hours.

 • Centrifuge 15 mL of culture for 10 min at 10.000 rpm. Resuspend the pellet with 15 mL saline.

 • Sonicate (amplitude of 20) the resuspended pellet 4x for 15 seconds.

 • Save the supernatant on ice for the experiments.

• Make different pH samples (pH 0,3/4,3/7,3/10,3/14) by combining different concentrations of 1 M NaOH and 1 M HCL.

 • Take 100 µl of the chromoprotein + µl 100 of the different pH samples.

 • Mix well.

 • As negative control, saline will be used.

 • Measure the absorbance with a Synergy™ LX Multi-Mode Microplate Reader at full spectrum (300-1000 nm).

*iGEM team Hogeschool Rotterdam*

[![Linkedin logo](https://static.igem.org/mediawiki/2019/8/84/T--Rotterdam_HR--linkedin.png)](https://www.linkedin.com/company/igem-rotterdam)
[![Facebook logo](https://static.igem.org/mediawiki/2019/e/e8/T--Rotterdam_HR--facebook.png)](https://www.facebook.com/igemhr/?hc_ref=ARQCF3aGY580IHKKok-Dt_Sy25wJXxXg9lV4ghMBmUMpBr2RanOYaycthIvgTkCrvpk&fref=nf&__xts__[0]=68.ARAssr3NbdC1PP_Erx6mgzTbkSOsKbtxw3XyX-g080UHQgFykE-p17cRLL3qf_VIYtv7mQTFEr7Lj_j1NY_VuawM5tZFYlxgrD9vmP4VxUSUJZn9E0IGD9T0LmCAfnj2Mkz_EZUL2KgOwZN6gMylEirLQb89pgG3lGGUwJ1vc1ANw_QeYguVLPESQbHb5Q_F-OlrQ-KBCE31pCDNaFt66KcDmbuBfmd2Zr6sKfy2nD1cf7sWqMCedR9a5q6MVqa0zGCoDxX-hTyXFSogr1Al04G_hB4dikoKdNahS9PZtIAtoLQ9W6PEYLgfetBURxOIDv090o7NEC3qPBZwm6y3wxo&__tn__=kC-R)
[![Instagram logo](https://static.igem.org/mediawiki/2019/a/a6/T--Rotterdam_HR--instagram.png)](https://www.instagram.com/igemhr/)
[![YouTube logo](https://static.igem.org/mediawiki/2019/e/e2/T--Rotterdam_HR--youtube.png)](https://www.youtube.com/channel/UCK5aND_p4WF1FRHU_R57lug)
![Instagram logo](https://static.igem.org/mediawiki/2019/7/7f/T--Rotterdam_HR--mail.png)

[![](https://2019.igem.org/wiki/images/8/8b/HQ_page_logo.jpg)](https://2019.igem.org)

# Team:Rotterdam HR/Results

![](https://static.igem.org/mediawiki/2019/e/e9/T--Rotterdam_HR--logo.png)

# iGEM Rotterdam HR 2019

* [Home](https://2019.igem.org/Team%3ARotterdam_HR)

Team

[Members](https://2019.igem.org/Team%3ARotterdam_HR/Members)
 [Collaborations](https://2019.igem.org/Team%3ARotterdam_HR/Collaborations)

Project

[Description](https://2019.igem.org/Team%3ARotterdam_HR/Description)
 [Safety](https://2019.igem.org/Team%3ARotterdam_HR/Safety)

Human Practices

[iGEM Squeeze](https://2019.igem.org/Team%3ARotterdam_HR/iGEMSqueeze)
 [Human Practices](https://2019.igem.org/Team%3ARotterdam_HR/Human_Practices)
 [Public Engagement](https://2019.igem.org/Team%3ARotterdam_HR/PublicEngagement)
 [Outreach](https://2019.igem.org/Team%3ARotterdam_HR/Outreach)

Acknowledgements

[Attributions](https://2019.igem.org/Team%3ARotterdam_HR/Attributions)
 [Sponsors](https://2019.igem.org/Team%3ARotterdam_HR/Sponsors)

Design

[Design](https://2019.igem.org/Team%3ARotterdam_HR/Design)

Lab

[Biobrick Parts](https://2019.igem.org/Team%3ARotterdam_HR/BioBricks)
 [DryLab](https://2019.igem.org/Team%3ARotterdam_HR/Drylab)
 [Notebook](https://2019.igem.org/Team%3ARotterdam_HR/NoteBook)
 [Results](https://2019.igem.org/Team%3ARotterdam_HR/Results)
 [Protocols](https://2019.igem.org/Team%3ARotterdam_HR/Experiments)

Future

[Future plans for our HRDK](https://2019.igem.org/Team%3ARotterdam_HR/Future)

# Results

# gBLOCKs

The gBLOCKs coding for fusion proteins of N-/C-TEV with the zinc finger arrays was designed on www.zincfingertools.com as previously described in our Drylab page.

Sense and antisense strands (IDT) were annealed and analyzed on 0.8% agarose gel (Figure 1).
![](https://static.igem.org/mediawiki/2019/0/02/T--Rotterdam_HR--resultspage1.PNG)

 Figure 1: gBLOCKs 1 and 2 on 0,8% agarose gel. 2-Log DNA ladder of New England Biolabs (NEB) is used as marker.

 The pSB1T3 and pSB1A3 plasmids gave the two bands that came close to our expectation after digestion with the restriction enzymes EcoRI and PstI (figure 2).

![](https://static.igem.org/mediawiki/2019/9/97/T--Rotterdam_HR--resultpage2.PNG)

 Figure 2: pSB1T3, pSB1A3 and gBLOCK2 on 0,8% agarose gel. 2-log DNA ladder (NEB) is used as marker. \* Digested

 Unfortunately, the ligation of pSB1A3 or pSB1T3 with gBLOCK2 did not work because all the colonies (and the negative control) were pink. The pSB1T3 and pSB1A3 plasmids both contain the RFP coding device (BBa\_J04450), this means it will have a pink color. When a BioBrick has been inserted into this plasmid, it will result in a white color because the RFP coding device will be cut out of the plasmid with the restriction enzymes. So, the pink colonies mean that no insert has been introduced into the iGEM plasmid (Figure 3) and thereby we think that the ligation of our gBLOCK into the plasmid did not happen. As negative control only the dephosphorylated plasmid (pSB1A3 or pSB1T3) has been used, so without the gBLOCK2.

![](https://static.igem.org/mediawiki/2019/a/a4/T--Rotterdam_HR--result4.jpeg)

 Figure 3: Results of the transformation of pSB1A3 with gBLOCK2 on the left. On the right the negative control.

 After redoing the experiment multiple times, we only got “empty” agar plates. This was not due to the transformations, because within the same experiment we also transformed a pUC35 plasmid and this resulted in multiple colonies on the agar plate. So, probably there went something wrong with the ligation step. For the ligation, different kits were used to be sure that the materials of the kit worked, these kits gave the same results. The pUC35 plasmid was digested with a different restriction enzyme compared to the pSB1A3 plasmid. Therefore, it is possible that something went wrong with the digestions.

 Before we pursued further experimentation, we focused on amplifying our DNA of gBLOCK2 by PCR. After many experiments, the DNA concentration of gBLOCK2 was not enough to proceed. The PCR gel extraction resulted in low DNA concentrations, these were too low to use it for further experiments. Therefore the focus was on other experiments instead.

# DNA bridges

Unfortunately, our DNA bridges are being held at Customs in Rotterdam. Therefore we also didn’t work with aptamers because we first wanted to know the ideal distance and orientation for the TEV proteins and if the rest of the system could work. We did not want to waste our resources and rather focused on other parts of the system.

![](https://static.igem.org/mediawiki/2019/d/d0/T--Rotterdam_HR--result5.png)

# Update

 After we came back from Boston the DNA bridges finally arrived!

![](https://static.igem.org/mediawiki/2019/f/fb/T--Rotterdam_HR--dnabridgeupdated.png)

# TEV-cleaving site – β-Lactamase

TEV will only “cleave off” β-Lactamase (bla) from its inhibitor if there is a TEV-cleaving site. To find an inhibitor protein, multiple (random) proteins had to be tested. For this reason, bla coding constructs with N-terminal or C-terminal TEV-cleaving sites were created after performing a fusion PCR. For the fusion PCR pUC18 has been used as a template. Different fragments with bla and TEV were made by using different primers as described in the Protocols page. The last primers that are used for the fusion PCR contain the RFC10 prefix or suffix site.

![](https://static.igem.org/mediawiki/2019/d/d5/T--Rotterdam_HR--resultpage3.PNG)

 Figure 4: Fusion product of the TEV-cleaving site with bla on 0,8% agarose gel.

After performing the fusion PCR, a product with the TEV-cleaving site attached to bla had been made which is shown in Figure 4. This product and the plasmid pSB1C3 were cut with restriction enzymes XbaI and SpeI. This resulted in multiple-bands on the gel that were not expected, we concluded that the plasmid pSB1C3 wasn't a suitable plasmid to use.

Because restriction enzymes tend not to cut well near the end of PCR products, the option was to clone the TEV-cleaving site-bla product by blunt-end ligation into a cloning vector. The pUC35 is a pUC18 derived plasmid with a chloramphenicol resistance marker instead of the ampicillin resistance marker. This plasmid was constructed by other students of the Rotterdam University of Applied Sciences. The TEV-cleaving site-bla product was ligated into the pUC35 plasmid that was digested with SmaI-HF. After transformation and blue-white screening, the plasmid DNA of the white colonies were isolated and sent for sequencing. From the sequence results, we concluded that no TEV-cleaving site-bla fusion constructs had been obtained.

# TEV

We have fusion proteins in the isolated form of GST-TEVcleavingsite-BRCA2peptide (GST-TEV-BRCA2) and functional TEV proteins. This combination could serve as a positive control for experiments on TEV-cleaving site-bla fusion constructs. We made a mix of the two proteins and incubated them on 37 ⁰C. Samples were taken 1 hour, 2 hours and 4 hours after incubation initiation. This was done in duplicate. In lanes 1-4 and 6-7 (Figure 5) GST-TEV-BRCA2 is visible which has been incubated with the TEV protein. A split in the protein is seen, however, the TEV protein itself is not visible on the gel. Lanes 8 and 9 should show only TEV protein, but no bands that indicate presence of TEV are visible.

 The same experiment was repeated, but however, reproducing the experiment gave different distinct results. In one of the results, the fusion proteins were undigested and remained far above in the gel, and TEV was again invisible. In order to avoid doing experiments with samples that may not contain the TEV protein at all, we recommend HPLC analysis for future experimenting. This will result in more specific detection of the presence of TEV proteins.

![](https://static.igem.org/mediawiki/2019/3/3e/T--Rotterdam_HR--resultspage4.PNG)

 Figure 5: Testing TEV with GST-TEV-BRCA2 on 10% SDS-PAGE gel. Blue Prestained Protein Standard(NEB) is used as marker.

# Nitrocefin

![](https://static.igem.org/mediawiki/2019/thumb/8/8e/T--Rotterdam_HR--result9.jpg/220px-T--Rotterdam_HR--result9.jpg)

 Figure 6: Nitrocefin test of a bacteria with ampicillin resistance. On the top you can see the negative control, on the bottom the two test samples are shown.

 A one-month-old bacteria with ampicillin resistance has been used to look if the nitrocefin shows a color change in the presence of β-Lactamase. The bacteria have been resuspended in phosphate buffer, so as negative control phosphate buffer was used. After 8 minutes the color changed from yellow to red. Nitrocefin could be used in the lab for testing the system, but nitrocefin is less safe for our final product. So, a replacement is needed.

# Chromoproteins

One of the criteria for bronze is to perform characterization tests on parts from the registry. Our choice was to characterize the absorbance spectra of the chromoproteins made by the iGEM team Uppsala in 2013. An addition to the characterization tests is to see whether there will be a change in the absorbance spectrum when the proteins are suspended in acidic or basic environments.

For the first experiment, a full-spectrum analysis(300-1000 nm) of fresh lysate chromoproteins purple (BBa\_K1033917) and pink (BBa\_K1033926) was performed. Results can be seen in Figures 8-11.

 The second characterization experiment (figures 13-16) was to test the effect of pH: 0.3, 4.3, 7.3, 10.3 and 14. The tests have been performed twice in different wells of a 96-wells plate, 100 uL of each chromoprotein sample was mixed with 100 uL of different pH-samples.

![](https://static.igem.org/mediawiki/2019/1/18/T--Rotterdam_HR--result10.jpg)

Figure 7: Absorbance spectrum of saline.

![](https://static.igem.org/mediawiki/2019/9/9c/T--Rotterdam_HR--result11.jpg)

Figure 8: Full spectrum analysis of asPink.

![](https://static.igem.org/mediawiki/2019/5/52/T--Rotterdam_HR--result12.jpg)

Figure 9: Duplicate of the full spectrum analysis of asPink.

![](https://static.igem.org/mediawiki/2019/f/f2/T--Rotterdam_HR--result13.jpg)

Figure 10: Full spectrum analysis of gfasPurple.

![](https://static.igem.org/mediawiki/2019/6/61/T--Rotterdam_HR--result14.jpg
)

Figure 11: Duplicate of the full spectrum analysis of gfasPurple.

For the different pH experiments, the results are shown below.

![](https://static.igem.org/mediawiki/2019/4/45/T--Rotterdam_HR--result15.jpg)

Figure 12: Full spectrum pH-analysis of asPink.

![](https://static.igem.org/mediawiki/2019/7/7e/T--Rotterdam_HR--result16.jpg)

Figure 13: Duplicate of the full spectrum pH-analysis of asPink.

![](https://static.igem.org/mediawiki/2019/8/8e/T--Rotterdam_HR--result18.jpg)

Figure 14: Full spectrum pH-analysis of gfasPurple.

![](https://static.igem.org/mediawiki/2019/4/49/T--Rotterdam_HR--design2.png)

Figure 15: Duplicate of the full spectrum pH-analysis of gfasPurple.

 In conclusion, increasing the pH of the suspension sample shifts the absorbance spectrum of both chromoproteins to the left starting from pH7.3 (natural conditions in the cell), to decreasing wavelength.

*iGEM team Hogeschool Rotterdam*

[![Linkedin logo](https://static.igem.org/mediawiki/2019/8/84/T--Rotterdam_HR--linkedin.png)](https://www.linkedin.com/company/igem-rotterdam)
[![Facebook logo](https://static.igem.org/mediawiki/2019/e/e8/T--Rotterdam_HR--facebook.png)](https://www.facebook.com/igemhr/?hc_ref=ARQCF3aGY580IHKKok-Dt_Sy25wJXxXg9lV4ghMBmUMpBr2RanOYaycthIvgTkCrvpk&fref=nf&__xts__[0]=68.ARAssr3NbdC1PP_Erx6mgzTbkSOsKbtxw3XyX-g080UHQgFykE-p17cRLL3qf_VIYtv7mQTFEr7Lj_j1NY_VuawM5tZFYlxgrD9vmP4VxUSUJZn9E0IGD9T0LmCAfnj2Mkz_EZUL2KgOwZN6gMylEirLQb89pgG3lGGUwJ1vc1ANw_QeYguVLPESQbHb5Q_F-OlrQ-KBCE31pCDNaFt66KcDmbuBfmd2Zr6sKfy2nD1cf7sWqMCedR9a5q6MVqa0zGCoDxX-hTyXFSogr1Al04G_hB4dikoKdNahS9PZtIAtoLQ9W6PEYLgfetBURxOIDv090o7NEC3qPBZwm6y3wxo&__tn__=kC-R)
[![Instagram logo](https://static.igem.org/mediawiki/2019/a/a6/T--Rotterdam_HR--instagram.png)](https://www.instagram.com/igemhr/)
[![YouTube logo](https://static.igem.org/mediawiki/2019/e/e2/T--Rotterdam_HR--youtube.png)](https://www.youtube.com/channel/UCK5aND_p4WF1FRHU_R57lug)
![Instagram logo](https://static.igem.org/mediawiki/2019/7/7f/T--Rotterdam_HR--mail.png)